Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2029538e13ad43a75535f7dffbb3243 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-116 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
filingDate |
2009-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ecc45df6c45b633aadd1e9116432bad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b14f52b8a8923f682d718e2fb5761c2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2913f161e8f50948c0f462ba55e7f1ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6668d962e251aa3f258edbcf41eb146c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95699f7861aa1e11fd9b931b70467836 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2006695735fe7558e9c9d5881dcaeb6b |
publicationDate |
2009-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2726465-A1 |
titleOfInvention |
Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof |
abstract |
The present technology provides vaccine compositions comprising native outer membrane vesicles (NOMVs) from at least one genetically modified strain of Neisseria which provides protective immunity to meningococcal disease, more preferably subtype B meningococcal disease. The present technology further provides methods of immunizing an animal or human against meningococcal disease comprising administering the vaccine composition of the present invention. |
priorityDate |
2008-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |